Dan Clark

What are you thinking in terms of the macro and in terms of fuel prices? Do you assume sort of no change in that dynamic going forward

Where are we sort of in terms of placements into the larger corporate practices

would it be fair to kinda take the second half of '25 run rate for non-wellness and extrapolate that forward

Was there any impact on headline visit numbers in the quarter as you've lapped that launch

what gets us up to the 15%, 16% range? Is it just continued sales rollout? Or what else should we be thinking about here

is there any reason to think more positively about the trajectory here relative to SediVue as an outlook

Is that a topic that comes up at all when you're discussing, you know, potential inVue sales with your customers?

was there any impact from weather that's worth calling out in terms of visit trends for 4Q

Are you still limiting preorders or are you fully allowing those now?

are you seeing more CROs on average in an RFP? And are there any changes in pricing worth calling out

How are you kind of thinking about the contributions from price and margin -- price and volume, excuse me, kind of at the high and low ends of the range

How should we think about contributions from Invitae this year, given that you did a pretty good job integrating it thus far?

what are your expectations for the flu and respiratory season and any associated volumes there

Should we expect similar levels of both as we saw in 1Q through the rest of the year

I guess, sorry to just belabor this point again regarding the 3% to 5% operational growth that you expect for 2026

was that always when you expect it to launch? And if that's changed, like how did that impact your expectations for the year?

What are the different pushes and pulls that you think could maybe drive that number higher? And how are you thinking about that for 2025?